论文部分内容阅读
Objective: The study is a prospective, open, randomized multicenter phase Ⅲ clinical trial with two arms that aims to elucidate superiority of D2 plus No.14v lymph node dissection in comparison with standard D2 surgery in patients with curable distal gastric cancer staged cT4N+M0.